A single dose of MSC therapy could consist of billions of cells per patient. To sustainably meet this clinical demand, cell expansion processes must be transformed from static cultures to suspension-based systems. This application note describes an efficient approach to process optimization in a scale-down model for suspension-based cell expansion.
Read more to learn how to:
â€¢ Comprehensively screen media and components for optimal cell growth
â€¢ Rapidly characterize phenotypic and functional CQAs of MSCs
â€¢ Develop process knowledge early in development to set the stage for seamless scale-up